Author

E. Shinozaki

h-index 33 View on Semantic Scholar

We have 3 of 383 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Cytotoxic immune activity reflects a coordinated immune microenvironment and is associated with response to total neoadjuvant therapy in rectal cancer.

Erina Haraguchi, N. Tanaka, Kentaro Sato et al. · Journal of gastroenterology · 0 citations

Open access Aug 2026

Proteinuria as the cause of early dose modification in Japanese patients with metastatic colorectal cancer treated with fruquintinib: a multicenter real-world study.

BACKGROUND Fruquintinib has demonstrated survival benefits in patients with previously treated metastatic colorectal cancer (mCRC) in phase III trials. However, real-world data in Japanese patients remain limited. This study evaluated the effectiveness and safety of fruquintinib in routine clinical practice. METHODS...

Shohei Udagawa, Chihiro Ishizuka, H. Osumi et al. · International Journal of Cli... · 0 citations

Open access Aug 2026

Prognostic impact of circulating tumor RAS and BRAF mutation dynamics in patients with metastatic colorectal cancer

Summary Post-treatment alterations in circulating tumor DNA (ctDNA) hold potential for refining treatment strategies in metastatic colorectal cancer (mCRC). In this multi-institutional study of 1,391 patients from the SCRUM-Japan GOZILA platform, we evaluated the prognostic significance of post-treatment rat sarcoma vi...

H. Osumi, E. Shinozaki, Yoshiaki Nakamura et al. · iScience · 0 citations